The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Lippi G.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
Cadamuro J.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
von Meyer A.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
Simundic A-M.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
Practical recommendations for managing hemolyzed samples in clinical chemistry testing
Journal: Laboratory Service. 2023;12(1): 40‑49
Views: 1360
Downloaded: 32
To cite this article:
Lippi G, Cadamuro J, von Meyer A, Simundic A-M. Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Laboratory Service.
2023;12(1):40‑49. (In Russ.)
https://doi.org/10.17116/labs20231201140
We suggest here a pragmatic approach for managing results of clinical chemistry testing in hemolyzed samples collected from adults/older children, attempting to balance the need to produce quality laboratory data with clinical urgency of releasing test results. Automatic measurement of the hemolysis index (H-index) in serum or plasma is highly advisable, whilst low-quality assessment of this test remains less good than a visual inspection. Regarding its practical use, when the H-index value does not generate an analytically significant bias, results can be released, whilst when the value is associated with analyte variation in a range between analytically and clinically significant bias (i.e. variation does not exceed the reference change value [RCV]), results of hemolysis-sensitive tests can be released in association with a comment describing the direction in which data are potentially altered, suggesting the need to collect another sample. When the H-index is associated with analyte variation exceeding clinically significant bias (i.e. variation exceeds the RCV), results of hemolysis-sensitive tests should be suppressed and replaced with a comment that biased results cannot be released because the sample is preanalytically compromised and advising the recollection of another sample. If H-index values reach an even higher critical cut-off (i.e. H-index corresponding to a cell-free hemoglobin concentration ≥10 g/L), all laboratory data may be unreliable and should hence be suppressed and replaced with a comment that all data cannot be released because the sample is grossly hemolyzed, also suggesting the recollection of another sample. Due to inaccuracy and imprecision, the use of corrective formulas for adjusting data of hemolysis-sensitive tests is discouraged.
Keywords:
Authors:
Lippi G.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
Cadamuro J.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
von Meyer A.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
Simundic A-M.
On behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE)
Received:
15.02.2023
Accepted:
20.03.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.